abnormal xenobiotic pharmacokinetics_Slc22a1<tm1Kmgi>/Slc22a1<tm1Kmgi>

http://metadb.riken.jp/0008875I129P2OlaHsdC57BL6JFVBNSlc22a1tm1KmgiSlc22a1tm1KmgiSlc22a1tm1Kmgi

abnormal xenobiotic pharmacokinetics_Slc22a1<tm1Kmgi>/Slc22a1<tm1Kmgi>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• solute carrier family 22 (organic cation transporter), member 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:108111

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Slc22a1<tm1Kmgi>/Slc22a1<tm1Kmgi>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Slc22a1<tm1Kmgi>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6J * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal xenobiotic pharmacokinetics
  http://purl.obolibrary.org/obo/MP_0008875

文献

http://purl.org/net/cito/citesAsAuthority

• Yan. Shu, et.al., Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action., The Journal of clinical investigation, 2007, 117
  http://rdf.ncbi.nlm.nih.gov/pubmed/17476361